Status:
UNKNOWN
Post Market Multi-Center Retrospective Research on Embolization of Intracranial Aneurysms With Pipeline Embolization Device in China
Lead Sponsor:
Beijing Neurosurgical Institute
Collaborating Sponsors:
Xuanwu Hospital, Beijing
Henan Provincial People's Hospital
Conditions:
Intracranial Aneurysm
Pipeline Embolization Device
Eligibility:
All Genders
Brief Summary
Pipeline TM embolization device launched to China in 2014, and has been widely used to treat large width IA. Therefore, it is necessary to collect and analysis the clinical data to evaluate effectiven...
Detailed Description
Recent years, the rapid development of endovascular treatment, especially the introduction of blood flow diverter device, has led to a new step in the treatment of intracranial aneurysms. It is differ...
Eligibility Criteria
Inclusion
- Patients accepting to participate the study
- Patients treated with Pipeline
Exclusion
- Patients treated by parent vessel occlusion
- Patients treated by other stent
- Patients lacking 3-dimensional aneurysm images or the images not satisfied the simulation
Key Trial Info
Start Date :
November 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03831672
Start Date
November 1 2018
End Date
June 30 2019
Last Update
February 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Neurosurgical Institute and Beijing Tiantan Hospital affiliated to Capital Medical University
Beijing, Beijing Municipality, China, 100050